Alectinib: Capsule 150 mg; Alecensa®; Crizotinib: Capsule 200 mg; Capsule 250 mg; Xalkori® Page last updated: 6 March 2020 Public Summary Document (PSD) November 2019 PBAC Meeting - (PDF 706KB) Public Summary Document (PSD) November 2019 PBAC Meeting - (Word 181KB)